{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:12:03Z","timestamp":1789132323934,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005005","name":"Ben-Gurion University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mutations in the\n                      <jats:italic>UDP-galactose 4\u2019-epimerase<\/jats:italic>\n                      (GALE) gene disrupt the Leloir pathway of galactose metabolism and play a key role in protein and lipid glycosylation by providing essential nucleotide sugar donors. While GALE deficiency is known to cause galactosemia and thrombocytopenia, its impact on the human immune system remains largely unexplored. We aimed to characterize a novel immunodeficiency phenotype associated with the homozygous p.R51W GALE variant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a comprehensive immunological evaluation of seven pediatric patients (aged 2.5\u201310 years) homozygous for the p.R51W GALE variant. Assessments included immunoglobulin levels, vaccine-specific antibody responses, lymphocyte subsets, and kappa-deleting recombination excision circles (KRECs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patients exhibited profound B-cell lymphopenia (0.06\u20130.12\u2009\u00d7\u200910^3\/\u00b5l). While KREC levels were detectable, absolute counts (6\u201350 copies\/\u00b5L) were significantly below the age-specific 5th percentile, suggesting a quantitative defect in central B-cell output. Detailed B-cell phenotyping demonstrated preservation of the full spectrum of maturation stages, indicating no absolute block in differentiation. Serum IgA and IgM were consistently low, whereas IgG levels were preserved or elevated, driven by a paradoxical increase in the IgG3 subclass. Specific antibody responses were impaired. Clinically, patients suffered from recurrent viral respiratory infections but lacked invasive bacterial disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The p.R51W GALE variant results in a distinct hematopoietic stress phenotype characterized by significant quantitative B-cell deficiency. The absence of a clear differentiation block suggests that lymphopenia results from reduced central B-cell output combined with impaired peripheral homeostasis. We propose that the underlying GALE-mediated glycosylation defect compromises B-cell homeostasis. These findings identify GALE deficiency as a novel cause of primary immunodeficiency and suggest that immunological screening is warranted in affected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-026-02018-w","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:36:28Z","timestamp":1776303388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunological Manifestations in GALE Deficiency: Extending the Spectrum Beyond Thrombocytopenia and Galactosemia"],"prefix":"10.1007","volume":"46","author":[{"given":"Eyal","family":"Kristal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Khalaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Asleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed Abu","family":"Quider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotam David","family":"Eshel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim El","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurit","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Almashanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Miskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Staretz-Chacham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ben-Harosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"2","key":"2018_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gene.2013.04.061","volume":"524","author":"TJ McCorvie","year":"2013","unstructured":"McCorvie TJ, Timson DJ. In silico prediction of the effects of mutations in the human UDP-galactose 4\u2032-epimerase gene: towards a predictive framework for type III galactosemia. Gene. 2013;524(2):95\u2013104. https:\/\/doi.org\/10.1016\/j.gene.2013.04.061.","journal-title":"Gene"},{"issue":"5","key":"2018_CR2","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0021-9258(17)49882-6","volume":"295","author":"A Broussard","year":"2020","unstructured":"Broussard A, Florwick A, Desbiens C, et al. Human UDP-galactose 4\u2032-epimerase (GALE) is required for cell-surface glycome structure and function. J Biol Chem. 2020;295(5):1225\u201339.","journal-title":"J Biol Chem"},{"issue":"4","key":"2018_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10545-006-0382-0","volume":"29","author":"AM Bosch","year":"2006","unstructured":"Bosch AM. Classical galactosaemia revisited. J Inherit Metab Dis. 2006;29(4):516\u201325.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2018_CR4","first-page":"255","volume":"208","author":"DJ Timson","year":"2006","unstructured":"Timson DJ. Galactose metabolism in humans: enzymology, metabolic dysfunction and disease. J Pathol. 2006;208(3):255\u201366.","journal-title":"J Pathol"},{"key":"2018_CR5","doi-asserted-by":"crossref","unstructured":"Dias Costa F, Ferdinandusse S, Pinto C, et al. Galactose epimerase deficiency: expanding the phenotype. In: JIMD Reports. 2017;37:19\u201325.","DOI":"10.1007\/8904_2017_10"},{"key":"2018_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.metabol.2018.01.025","volume":"83","author":"D Demirbas","year":"2018","unstructured":"Demirbas D, Coelho AI, Rubio-Gozalbo ME, Berry GT. Hereditary galactosemia. Metabolism. 2018;83:188\u201396.","journal-title":"Metabolism"},{"issue":"2","key":"2018_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gene.2015.06.077","volume":"589","author":"DJ Timson","year":"2016","unstructured":"Timson DJ. The molecular basis of galactosemia\u2014past, present and future. Gene. 2016;589(2):133\u201341. https:\/\/doi.org\/10.1016\/j.gene.2015.06.077.","journal-title":"Gene"},{"issue":"1","key":"2018_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/498985","volume":"78","author":"KK Openo","year":"2006","unstructured":"Openo KK, Schulz JM, Vargas CA, et al. Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet. 2006;78(1):89\u2013102. https:\/\/doi.org\/10.1086\/498985.","journal-title":"Am J Hum Genet"},{"key":"2018_CR9","doi-asserted-by":"crossref","unstructured":"Seo A, Gulsuner S, Pierce S, et al. Inherited thrombocytopenia associated with mutation of UDP-galactose-4-epimerase (GALE). Hum Mol Genet. 2019;28(1):133\u2013142. https:\/\/doi.org\/10.1093\/hmg\/ddy334","DOI":"10.1093\/hmg\/ddy334"},{"issue":"4","key":"2018_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1182\/blood.2022016995","volume":"141","author":"A Mar\u00edn-Qu\u00edlez","year":"2023","unstructured":"Mar\u00edn-Qu\u00edlez A, Di Buduo CA, D\u00edaz-Ajenjo L, et al. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 2023;141(4):406\u201321. https:\/\/doi.org\/10.1182\/blood.2022016995.","journal-title":"Blood"},{"issue":"4","key":"2018_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood.2022019021","volume":"141","author":"A Braun","year":"2023","unstructured":"Braun A, Mammadova-Bach E. GALE force in platelet production. Blood. 2023;141(4):330\u20131.","journal-title":"Blood"},{"issue":"1","key":"2018_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther. 2024;9(1):194.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2018_CR13","first-page":"427","volume":"36","author":"J Jaeken","year":"2016","unstructured":"Jaeken J, et al. Immunological aspects of congenital disorders of glycosylation (CDG): a review. J Clin Immunol. 2016;36(5):427\u201333.","journal-title":"J Clin Immunol"},{"key":"2018_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188838","volume":"14","author":"S Trzos","year":"2023","unstructured":"Trzos S, Link-Lenczowski P, Poche\u0107 E. The role of N-glycosylation in B-cell biology and IgG activity. Front Immunol. 2023;14:1188838.","journal-title":"Front Immunol"},{"issue":"1","key":"2018_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imr.13407","volume":"328","author":"J Kri\u0161ti\u0107","year":"2024","unstructured":"Kri\u0161ti\u0107 J, Lauc G. The importance of IgG glycosylation. Immunol Rev. 2024;328(1):143\u201370. https:\/\/doi.org\/10.1111\/imr.13407.","journal-title":"Immunol Rev"},{"key":"2018_CR16","doi-asserted-by":"crossref","unstructured":"Markovitz R, Owen N, Satter LF, et al. Expansion of the clinical phenotype of GALE deficiency. Am J Med Genet A. 2021;185(10):3118\u20133121.","DOI":"10.1002\/ajmg.a.62384"},{"key":"2018_CR17","doi-asserted-by":"crossref","unstructured":"Medova V, Hulinkova I, Laiferova N, et al. Age-specific TREC\/KREC levels for detection of inborn errors of immunity. Clin Immunol. 2022;245:109155. https:\/\/doi.org\/10.1016\/j.clim.2022.109155","DOI":"10.1016\/j.clim.2022.109155"},{"key":"2018_CR18","doi-asserted-by":"crossref","unstructured":"Kwok JSY, Cheung SKF, Ho JCY, et al. Simultaneous TREC and KREC assays and reference intervals in healthy individuals. Front Immunol. 2020;11:1411. https:\/\/doi.org\/10.3389\/fimmu.2020.01411","DOI":"10.3389\/fimmu.2020.01411"},{"key":"2018_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1350101","volume":"15","author":"C Pascoal","year":"2024","unstructured":"Pascoal C, Francisco R, Mexia P, et al. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review. Front Immunol. 2024;15:1350101.","journal-title":"Front Immunol"},{"key":"2018_CR20","unstructured":"Stray-Pedersen A, et al. PGM3 mutations cause a CDG with severe immunodeficiency, neutropenia and skeletal anomalies. Am J Hum Genet. 2014;95(2):241\u2013248."},{"key":"2018_CR21","unstructured":"Boztug K, et al. JAGN1 deficiency causes aberrant glycosylation and impaired neutrophil function. Nat Genet. 2014;46(3):234\u2013239."},{"key":"2018_CR22","doi-asserted-by":"crossref","unstructured":"Verheijen J, Wong SY, Rowe JH, et al. MAN2B2-CDG: defining a new immune deficiency syndrome. J Allergy Clin Immunol. 2020;145(3):1008\u20131011. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.016","DOI":"10.1016\/j.jaci.2019.11.016"},{"key":"2018_CR23","doi-asserted-by":"crossref","unstructured":"Febres-Aldana CA, Pelaez L, Wright MS, et al. UDP-galactose 4\u2032-epimerase deficiency with dyshematopoiesis and cardiac malformations. Mol Syndromol. 2020;11(5\u20136):320\u2013330. https:\/\/doi.org\/10.1159\/000511343","DOI":"10.1159\/000511343"},{"issue":"17","key":"2018_CR24","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1302846","volume":"370","author":"MA Sadat","year":"2014","unstructured":"Sadat MA, Moir S, Chun TW, Lusso P, Kaplan G, Wolfe L, et al. Glycosylation, hypogammaglobulinemia, and resistance to viral infections. N Engl J Med. 2014;370(17):1615\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1302846.","journal-title":"N Engl J Med"},{"issue":"5","key":"2018_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","volume":"40","author":"JC Ravell","year":"2020","unstructured":"Ravell JC, Chauvin SD, He T, Lenardo M. An update on XMEN disease. J Clin Immunol. 2020;40(5):671\u201381. https:\/\/doi.org\/10.1007\/s10875-020-00790-x.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02018-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02018-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02018-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:08:17Z","timestamp":1781647697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02018-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2018"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02018-w","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of Soroka University Medical Center (0250-04-SOR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patients\u2019 legal guardians for inclusion in this study and for the publication of clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}